Type2diabetes

Metabolic·MeSH: Diabetes Mellitus, Type 2

8 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Phase 1(7)

Drug	Company
arm 1 - dehydratech-cbd alone	Lexaria Bioscience Corp. (LEXX)
arm 2 - dehydratech-semaglutide alone	Lexaria Bioscience Corp. (LEXX)
arm 4 - rybelsus medication alone	Lexaria Bioscience Corp. (LEXX)
arm 5- tirzepatide	Lexaria Bioscience Corp. (LEXX)
dehydratech-cbd	Lexaria Bioscience Corp. (LEXX)
dehydratech-semaglutide	Lexaria Bioscience Corp. (LEXX)
dehydratech-tirzepatide	Lexaria Bioscience Corp. (LEXX)

Preclinical(1)

Drug	Company
dehydratech-liraglutide	Lexaria Bioscience Corp. (LEXX)

BioSniper tracks 8 drugs in development for Type2diabetes across 1 company.

There are 1 clinical trial targeting Type2diabetes tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.